TrialGynecologic oncology2011

Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study.

John Farley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.